Montagu-backed RTI Surgical, a contract development and manufacturing organization, completed the acquisition of Cook Biotech, a tissue-repair products developer, from Cook Group, a medical devices manufacturer. Financial terms were not disclosed. "We are excited to welcome the Cook Biotech team and leverage our unmatched expertise in soft tissue to enhance patients' lives and outcomes. We are proud to offer customers and surgeons an innovative, clinically proven portfolio of differentiated allograft and xenograft biomaterials to better address the unique needs of individual patients," Olivier Visa, RTI Surgical President and CEO.